Search research articles
Contact Us
Filters
Showing results (11-20 of 409) with videos related to
Page
of 41
Sort By:
Seminars in Cancer Biology
|
June 20, 2006
Prostate stem cells: from development to cancer
Sabina Signoretti, Massimo Loda
Cancer Cell
|
April 14, 2010
Prostate cancer: beta control your hormones
Massimo Loda, William G Kaelin
Cancer Cell
|
November 27, 2002
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?
William R Sellers, Massimo Loda
The Journal of Pathology
|
December 3, 2010
Metabolic alterations and targeted therapies in prostate cancer
Richard Flavin, Giorgia Zadra, Massimo Loda
The Urologic Clinics of North America
|
February 16, 2010
Blood and tissue biomarkers in prostate cancer: state of the art
Michelangelo Fiorentino, Elisa Capizzi, Massimo Loda
Diagnostic Histopathology (Oxford, England)
|
October 19, 2010
The pathogenesis of prostate cancer: from molecular to metabolic alterations
Elisa Benedettini, Paul Nguyen, Massimo Loda
European Urology Oncology
|
April 2, 2019
The Metabolic Landscape of Prostate Cancer
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda
Biochimica Et Biophysica Acta
|
April 9, 2013
The fat side of prostate cancer
Giorgia Zadra, Cornelia Photopoulos, Massimo Loda
Expert Opinion on Medical Diagnostics
|
March 19, 2013
Multispectral imaging and pathology: seeing and doing more
Richard M Levenson, Alessandro Fornari, Massimo Loda
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 14, 2002
Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells
Michael H Weinstein, Sabina Signoretti, Massimo Loda
Page
of 41
Search research articles
Search
Showing results (11-20 of 409) with videos related to
Sort By:
Page
of 41
Seminars in Cancer Biology
|
June 20, 2006
Prostate stem cells: from development to cancer
Sabina Signoretti, Massimo Loda
Cancer Cell
|
April 14, 2010
Prostate cancer: beta control your hormones
Massimo Loda, William G Kaelin
Cancer Cell
|
November 27, 2002
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?
William R Sellers, Massimo Loda
The Journal of Pathology
|
December 3, 2010
Metabolic alterations and targeted therapies in prostate cancer
Richard Flavin, Giorgia Zadra, Massimo Loda
The Urologic Clinics of North America
|
February 16, 2010
Blood and tissue biomarkers in prostate cancer: state of the art
Michelangelo Fiorentino, Elisa Capizzi, Massimo Loda
Diagnostic Histopathology (Oxford, England)
|
October 19, 2010
The pathogenesis of prostate cancer: from molecular to metabolic alterations
Elisa Benedettini, Paul Nguyen, Massimo Loda
European Urology Oncology
|
April 2, 2019
The Metabolic Landscape of Prostate Cancer
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda
Biochimica Et Biophysica Acta
|
April 9, 2013
The fat side of prostate cancer
Giorgia Zadra, Cornelia Photopoulos, Massimo Loda
Expert Opinion on Medical Diagnostics
|
March 19, 2013
Multispectral imaging and pathology: seeing and doing more
Richard M Levenson, Alessandro Fornari, Massimo Loda
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 14, 2002
Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells
Michael H Weinstein, Sabina Signoretti, Massimo Loda
Page
of 41